Improving pregnancy drug warnings to promote patient comprehension

Whitney B. You, William Grobman, Terry Davis, Laura M. Curtis, Stacy Cooper Bailey, Michael Wolf

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Objective We sought to evaluate the effectiveness of a pharmaceutical labeling strategy intended to improve comprehension of a teratogen warning. Study design This is a secondary analysis that evaluated women of childbearing age who were assigned prescription containers with the current teratogen warning, a label with simplified text, or a label with simplified text and icons. The association between label type and understanding of label instructions was assessed. Results A total of 132 women were interviewed. Comprehension of the icon label (94%) was higher than for the standard and enhanced text-only labels (76% and 79%), respectively (P < .05). Adjustment for age, race/ethnicity, education, literacy, and number of current medications revealed that the label with the enhanced text and icon yielded superior comprehension (risk ratio vs standard, 1.26; 95% confidence interval, 1.041.53; risk ratio vs enhanced, 1.22; 95% confidence interval, 1.021.46). Conclusion In our study, a teratogen warning label that had easy-to-read messages with icons significantly improved comprehension.

Original languageEnglish (US)
Pages (from-to)318.e1-318.e5
JournalAmerican journal of obstetrics and gynecology
Issue number4
StatePublished - Apr 2011


  • prescription
  • teratogen
  • warning

ASJC Scopus subject areas

  • Obstetrics and Gynecology


Dive into the research topics of 'Improving pregnancy drug warnings to promote patient comprehension'. Together they form a unique fingerprint.

Cite this